Vladimir Pelicic is a prominent inventor based in Paris, France. He has made significant contributions to the field of mycobacterial research, particularly in the development of innovative diagnostic and therapeutic methods for tuberculosis. With a total of 3 patents, his work has garnered attention in the scientific community.

Latest Patents

One of Pelicic's latest patents focuses on polypeptide nucleic sequences exported from mycobacteria, along with vectors that incorporate these sequences. This invention aims to improve the diagnosis and prevention of tuberculosis by utilizing recombinant vectors replicated in mycobacteria. The patent details a set of sequences coding for exported polypeptides, specifically highlighting a polypeptide known as DP428, which is approximately 12 kD in size. This polypeptide corresponds to an exported protein found in mycobacteria belonging to a specific complex. The invention also outlines methods and kits for detecting the presence of mycobacteria in biological samples, using the identified polypeptides and their fragments. Additionally, it discusses immunogenic or vaccine compositions designed to prevent and treat infections caused by mycobacteria, particularly those leading to tuberculosis.

Another significant patent involves a method for selecting allelic exchange mutants in mycobacterium strains. This process includes steps for replacing a nucleotide sequence within the genome of a mycobacterium strain, showcasing Pelicic's innovative approach to genetic manipulation in microbial research.

Career Highlights

Vladimir Pelicic is affiliated with the Institut Pasteur, a renowned research institution known for its contributions to microbiology and infectious diseases. His work at this prestigious institute has allowed him to explore groundbreaking research in mycobacterial genetics and its implications for public health.

Collaborations

Throughout his career, Pelicic has collaborated with esteemed colleagues, including Brigitte Gicquel and Jean-Marc Reyrat. These partnerships have further enriched his research and contributed to advancements in the understanding of mycobacterial diseases.

Conclusion

Vladimir Pelicic's innovative work in mycobacterial research has led to significant advancements in the diagnosis and treatment of tuberculosis. His contributions, reflected in his patents and collaborations, continue to impact the field and enhance our understanding of infectious diseases.

Profile summary based on public USPTO records.

Please report any incorrect information to [email protected]